Johnson & Johnson’s recently made public that its EVP, Innovative Medicine, R&D REED JOHN C unloaded Company’s shares for reported $3.13 million on Jul 17 ’25. In the deal valued at $163.55 per share,19,137 shares were sold. As a result of this transaction, REED JOHN C now holds 10,658 shares worth roughly $1.82 million.
Then, REED JOHN C bought 19,137 shares, generating $3,129,831 in total proceeds.
Before that, Decker Robert J sold 6,999 shares. Johnson & Johnson shares valued at $1,160,994 were divested by the VP Corporate Controller at a price of $165.88 per share. As a result of the transaction, Decker Robert J now holds 21,001 shares, worth roughly $3.59 million.
Erste Group upgraded its Johnson & Johnson [JNJ] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who decreased its forecast for the stock in mid May from “an Outperform” to “a Market perform”. Wolfe Research started covering the stock on November 15, 2024. It rated JNJ as “an Outperform”.
Price Performance Review of JNJ
On Monday, Johnson & Johnson [NYSE:JNJ] saw its stock jump 2.22% to $171.04. Over the last five days, the stock has gained 2.90%. Johnson & Johnson shares have risen nearly 8.36% since the year began. Nevertheless, the stocks have risen 18.27% over the past one year.
How much short interest is there in Johnson & Johnson?
A steep rise in short interest was recorded in Johnson & Johnson stocks on 2025-07-15, growing by 1.94 million shares to a total of 18.27 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 16.33 million shares. There was a rise of 10.63%, which implies that there is a positive sentiment for the stock.
